✦ LIBER ✦

A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis

✍ Scribed by G. Newson-Smith; M. Powell; M. Baehre; S. P. Garnham; M. T. MacMahon

Publisher: Springer-Verlag
Year: 1997
Tongue: English
Weight: 755 KB
Volume: 254
Category: Article
ISSN: 0302-9530
DOI: 10.1007/bf00874095

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy of potassium humate in

Clinical efficacy of potassium humate in the treatment of allergic rhinitis: double-blind placebo-controlled trial

✍ Justin J. Gandy; Johanna P. Meeding; Jacques R. Snyman; Constance E. Jansen van 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

A placebo-controlled study of sertraline

A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder

✍ Adam Moscovitch; CarlA. Blashko; JohnM. Eagles; Guy Darcourt; Christopher Thomps 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 209 KB

A randomized placebo-controlled study of

A randomized placebo-controlled study of the efficacy of antimuscarinics in the treatment of pediatric overactive bladder and incontinence

✍ Steve J. Hodges; Anthony Atala 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 191 KB

A double-blind controlled trial comparin

A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis

✍ Dr Alfred D. Steinberg; John L. Decker 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

Cianopramine and amitriptyline in the tr

Cianopramine and amitriptyline in the treatment of depressed patients — a placebo-controlled study

✍ L. Hormazabal; L. M. O. Omer; S. Ismail 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 330 KB

3-Cyano-imipramine (cianopramine) is a potent and selective inhibitor of serotonin uptake into synaptosomes. In a double-blind trial, 60 patients with various types of depression fulfilling the DSM-III criteria of depressive episodes were treated with either cianopramine (n=20, mean daily dose 3.3\_

Double-blind, placebo-controlled study t

Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

✍ Francesca Mancini; Roberta Zangaglia; Silvano Cristina; Maria Grazia Sommaruga; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

## Abstract Drooling is a frequent symptom in Parkinson's disease (PD), occurring in almost 75% of all patients. Although it is now well known that drooling in PD is the result of swallowing difficulties rather than excessive saliva production, few treatments have been developed to reduce it. Clini